CM Yediyurappa would be holding a meeting in the evening where a detailed discussion will take place on the extension of lockdown following which a decision will be taken.
www.news18.com
“Dr Ella has assured me that their facility at Malur in Kolar will be able to produce one crore vaccines by June- end. will be by two to three crores, and their target by August-end is four crore to five crore vaccine doses," Sudhakar said.
“Our priority is to get the vaccines to the people of our state at the earliest," Sudhakar said. He also said that
Bharat Biotech’s facility in Hyderabad can produce one crore doses of COVID vaccine a month whereas the Karnataka unit will roll out four to five crore doses a month from August onwards.
Earlier this week, Paul informed that Bharat Biotech is ready to share its technology with other manufacturers to ramp up the production.Today, Paul stated that the decision to increase the gap between 2 doses of Covishield to 12 weeks was not taken under pressure or due to shortage of doses
www.livemint.com
In an official statement, the ministry said, "To augment the capacity of Indigenous production of Covaxin under the Mission, the Department of Biotechnology, Government of India in April, 2021 provided financial support as Grant to vaccine manufacturing facilities for enhanced production capacities,
which is expected to reach more than 10 crore doses per month by September, 2021."
Serum Institute and Bharat Biotech have submitted to the Centre that they can ramp up production of Covishield and Covaxin to 10 crore and 7.8 crore doses, respectively, by August.
www.indiatvnews.com
Amid multiple states reporting a shortage of COVID-19 vaccine,
Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can ramp it up to
10 crore and 7.8 crore doses respectively by August
Dr V Krishna Mohan, the Whole-time Director of Bharat Biotech, is learnt to have conveyed to the government that the production of Covaxin would be raised to
3.32 crore in July, and to 7.82 crore in August which will be
maintained in September too.
Covishield would be ramped up to
10 crore doses each in August and will be
maintained at that level in September
=====
Current:
In a submission before the Supreme Court on May 9, the government has said that the Covid-19 vaccine manufacturing capacity of India for three vaccines - Covishield, Covaxin and Sputnik V - could cumulatively cross 14 crore doses a month by July 2021
www.businesstoday.in
In a submission before the Supreme Court on May 9, the government has said that the Covid-19 vaccine manufacturing capacity of India for three vaccines -
Covishield, Covaxin and Sputnik V - could cumulatively cross 14 crore doses a month by July 2021
The government affidavit revealed that the Serum Institute of India has ramped up production from 5 crore doses of Covidshield a month to 6.5 crore doses per month now, and is expected to further ramp-up by July 2021.
Bharat Biotech Intl Ltd has increased Covaxin production from 90 lakh a month to 2 crore doses a month now, and is expected to increase it further up to 5.5 crore doses a month by July 2021. In the case of Sputnik-V, the government said the production is expected to increase from 30 lakhs to 1.2 crore doses a month by July 2021.